Anavex Life Sciences Corp (AVXL)

[falconer66a]

The Whys of the New Employee

Today, Anavex Life Sciences Corp “announced the appointment of David Goldberger, RPh, MLS as Senior Vice President Regulatory Affairs.”

https://www.anavex.com/post/anavex-life-sciences-appoints-senior-vp-of-regulatory-affairs?mc_cid=f501bfbc9b&mc_eid=39975e48cc

What questions can be asked about this new employee?

1. Why did Anavex hire the fellow?

He’s not any low-level bloke of moderate skills or responsibilities. He’s an experienced medical/pharmaceutical professional, with “over 40 years of pharmacy practice and pharmaceutical industry experience.” He’s being paid an executive-level salary. Not cheap for Anavex.

Consequently, Anavex must think its money will be well-spent on this new employee. He is expected to bring useful competencies to Anavex’s efforts to get drugs approved for sales and clinical use (and not just in the US).

2. Why did this fellow choose to align the rest of his professional career with Anavex?

Why would he choose to sign on to a start-up biotech that has no sales revenues nor any product approved for sale? Would appear that he’s risking the rest of his professional career. If he and Anavex fail to gain sales and use approval for any of Anavex’s candidate drugs, what, then, will be the remainder of Mr. Goldberger’s career? “Well, that Mr. Goldberger tried his best at Anavex, but he made a big mistake. Anavex’s candidate drugs were simply failures, right from the start. Sad story. He shoulda known better! The rest of us did.”

This question has been asked when pondering other new Anavex high-level employees: What, exactly, might Goldberger have known or learned about the deep science and incompletely-revealed clinical evidence for blarcamesine and Anavex 3-71? Does he know only what posters (pro and con) on this message board know? Or, after an NDA (non-disclosure agreement) was signed, has Anavex taken Goldberger behind closed doors to scrutinize yet-unrevealed clinical data; information that prompted him to sign on with Anavex; information that obviated any subsequent risks for the rest of his professional career?